Searchable abstracts of presentations at key conferences in endocrinology

ea00100oc2 | Oral Communications | SFEEU2024

Non-islet cell tumour hypoglycaemia in adrenocortical carcinoma responding to combined growth hormone and corticosteroid therapy

Plowman C E , Soruna O , Pittaway J , Goodchild E , Shamash J , Chung TT , Abdel-Aziz T E , M Drake W

Case History: A 26-year-old woman with known metastatic adrenocortical carcinoma (ACC) was transferred to our department with recurrent severe hypoglycaemic episodes. Her ACC was diagnosed in 2018 and a 175 × 130 × 89 mm 1200 g mass was surgically resected (ENS@T stage-II, Weiss score-5, Ki-67 20%, Helsinki score-28). Her disease progressed despite adjuvant radiotherapy, mitotane and three chemotherapy regimens. In January 2023, she began experiencing episodes of pro...

ea0083erco4 | Endocrine-related Cancer | EYES2022

Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma (ACC)

O Kimpel , P Schindler , L Schmidt-Pennington , B Altieri , F Megerle , R Steenaard , J Pittaway , M Quinkler , K Mai , M. Kroiss , B Polat , M. Fassnacht

Background: The ESE-ENSAT guidelines emphasize the role of local therapies and suggest radiotherapy (RT) as an individualized treatment in patients with advanced ACC. However, the evidence for this recommendation is very low.Objectives: The aim of this study was to retrospectively investigate the efficacy and tolerance of RT in advanced ACC.Methods: We screened all patients in five European reference centers for ACC since 2000 for ...